Ibn Sina Pharma reviews manager incentives
Ibnsina Pharma is scheduled to hold its extraordinary general assembly meeting on September 1, 2026, to approve a reward and incentive system for the executive managers and board members through a promise of sale, including determining the number of shares and methods of financing their issuance or purchase. Additionally, amendments will be made to certain articles of the company's bylaws. The system aims to enhance management performance and achieve the company's financial goals. The financial implications of its implementation will be discussed, and the competent authorities will be authorized to complete the necessary procedures to approve it by the Financial Regulatory Authority.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)